Industry Outlook of Bio Medica Laboratories IPO
India’s pharmaceutical sector plays a significant role in the country’s economy and contributes to the global healthcare ecosystem.
The industry ranks third worldwide in pharmaceutical production by volume and 14th by value.
India is often referred to as the “Pharmacy of the World” due to its large-scale manufacturing and export of generic medicines and vaccines.
The country supplies nearly 20% of global generic medicines by volume, reflecting its presence in international pharmaceutical markets.
India also contributes more than 60% of global vaccine demand through domestic manufacturing and exports.
As of 2024, the pharmaceutical industry in India includes over 3,000 companies and more than 10,000 manufacturing units.
India has the highest number of USFDA-compliant pharmaceutical plants outside the United States.
The sector forms an important part of the global pharmaceutical supply chain, particularly for regulated regions such as the United States, the European Union, and Japan.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Bio Medica Laboratories IPO.